Medicine for treating osteoporosis and its prepn process

Abstract

The present invention discloses one kind of medicine for treating osteoporosis and its preparation process. The medicine is developed based on the Chinese medicine theory of benefiting liver and kidney to strengthen bones and muscles, and is prepared with seven kinds of Chinese medicinal materials, including malaytea scurfpea fruit, epimedium, wolfberry fruit, privet fruit, drynaria rhizome, cibot rhizome and cyathula root and proper amount of supplementary material. The medicine has the functions of invigorating liver and kidney, strengthening bone and relieving pain, and possesses obvious curative effect on osteoporosis and no side effect. The medicine may be prepared into different preparation forms for different clinical requirements.

Description

[technical field] [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a Chinese patent medicine for treating osteoporosis and a preparation method thereof. The drug is mainly used for the treatment of liver and kidney deficiency in primary osteoporosis. [Background technique] [0002] Primary osteoporosis is a systemic bone disease characterized by decreased bone mass and degeneration of bone microstructure, resulting in increased bone fragility and prone to fractures. This disease is a common disease in the elderly and postmenopausal women . According to the random sampling survey in Beijing in recent years, the average prevalence rate of women over 50 years old is 34%, and that of men is 25%. With the prolongation of the average life expectancy of my country's population and the aging of society, the prevalence rate of this disease will also increase year by year. The direct consequence of osteoporosis is fr...

AI Technical Summary

Problems solved by technology

[0003] Western medicine is still in the research stage of the etiology and pathogenesis of osteoporosis, and has not yet reached an authoritative consensus. It is generally considered to be a complex result of the interaction of many factors such as genetics, hormones, nutrition, exercise, age, and immunity. Commonly used drugs In bone resorption inhibitors (such as estrogen, calcitonin, raloxifene, bisphosphonates, calcium, vitamin D, etc.) and bone formation stimulators (such as fluorine preparations, parathyroid hormone, growth hormone, Hormones, etc.), although these drugs have some effects, some curative effects are not exact, some are expensive, some have relatively large side effects, and some are easy to rebound after drug withdrawal, so they are not ideal drugs for the treatment of osteoporosis.